drugset / Trial / NCT00261326

Simvastatin Treatment of Patients With Acute Optic Neuritis

NCT00261326

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate if the simvastatin treatment improve the visual function after 3 months of the inclusion to this project and if the simvastatin influences the results on cerebral MRI after 3 and 6 months of the inclusion. In addition the development of new demyelinating relapses. In the patients with monosymptomatic acut optic neuritis to investigate whether the simvastatin reduces the risk to develop multiple sclerosis (MS).

Timeline

Start
2006-09
Primary completion
2010-01
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Simvastatin Small molecule 80 mg